THE BILE ACID PHOSPHOLIPID CONJUGATE URSODEOXYCHOLYL LYSOPHOSPHATIDYLETHANOLAMIDE EXERTS ANTI-FIBROGENIC EFFECTS AND INHIBITS EPITHELIAL-TO-MESENCHYMAL TRANSITION BY BLOCKING TGFβ1/SMAD2/3 SIGNALING

被引：0
|
作者：
Pathil, A. [1 ]
Mueller, J. [1 ]
Warth, A. [1 ]
Chamulitrat, W. [1 ]
Stremmel, W. [1 ]
机构：
[1] Univ Heidelberg, Inst Pathol, D-6900 Heidelberg, Germany
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60119-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
117
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [1] THE NOVEL BILE ACID PHOSPHOLIPID CONJUGATE URSODEOXYCHOLYL LYSOPHOSPHATIDYLETHANOLAMIDE EXERTS ANTI-FIBROGENIC EFFECTS BY INHIBITION OF TGFβ1/SMAD SIGNALING
    Pathil, Anita
    Mueller, Jan
    Warth, Arne
    Chamulitrat, Walee
    Stremmel, Wolfgang
    HEPATOLOGY, 2010, 52 (04) : 1279A - 1279A
  • [2] The bile acid-phospholipid conjugate Ursodeoxycholyl Lysophosphatidylethanolamide (UDCA-LPE) disturbs pro-fibrogenic Integrin and TGFβ signaling
    Su, Jie
    Gan-Schreier, Hongying
    Chamulitrat, Walee
    Stremmel, Wolfgang
    Pathil, Anita
    HEPATOLOGY, 2015, 62 : 899A - 899A
  • [3] AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition
    Lin, Hui
    Li, Nianshuang
    He, Huan
    Ying, Ying
    Sunkara, Shashank
    Luo, Lingyu
    Lv, Nonghua
    Huang, Deqiang
    Luo, Zhijun
    MOLECULAR PHARMACOLOGY, 2015, 88 (06) : 1062 - 1071
  • [4] TSC1 Activates TGF-β-Smad2/3 Signaling in Growth Arrest and Epithelial-to-Mesenchymal Transition
    Thien, Antje
    Prentzell, Mirja Tamara
    Holzwarth, Birgit
    Klaesener, Kathrin
    Kuper, Ineke
    Boehlke, Christopher
    Sonntag, Annika G.
    Ruf, Stefanie
    Maerz, Lars
    Nitschke, Roland
    Grellscheid, Sushma-Nagaraja
    Reth, Michael
    Walz, Gerd
    Baumeister, Ralf
    Neumann-Haefelin, Elke
    Thedieck, Kathrin
    DEVELOPMENTAL CELL, 2015, 32 (05) : 617 - 630
  • [5] Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway
    Liu, Ping
    Pei, Jing-Jing
    Li, Li
    Li, Jing-Wei
    Ke, Xiao-Ping
    CURRENT CANCER DRUG TARGETS, 2023, 23 (02) : 145 - 158
  • [6] Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells
    Chen, Wei
    Zhao, Kai
    Miao, Chenkui
    Xu, Aiming
    Zhang, Jianzhong
    Zhu, Jundong
    Su, Shifeng
    Wang, Zengjun
    ONCOTARGETS AND THERAPY, 2017, 10 : 1503 - 1512
  • [7] microRNA-141 inhibits TGF-β1-induced epithelial-to-mesenchymal transition through inhibition of the TGF-β1/SMAD2 signalling pathway in endometriosis
    Wang, Sixue
    Zhang, Mengmeng
    Zhang, Tingting
    Deng, Juan
    Xia, Xiaomeng
    Fang, Xiaoling
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (03) : 707 - 714
  • [8] Antrodin C Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Suppression of Smad2/3 and β-Catenin Signaling Pathways
    Kumar, K. J. Senthil
    Vani, M. Gokila
    Chueh, Pin-Ju
    Mau, Jeng-Leun
    Wang, Sheng-Yang
    PLOS ONE, 2015, 10 (02):
  • [9] microRNA-141 inhibits TGF-β1-induced epithelial-to-mesenchymal transition through inhibition of the TGF-β1/SMAD2 signalling pathway in endometriosis
    Sixue Wang
    Mengmeng Zhang
    Tingting Zhang
    Juan Deng
    Xiaomeng Xia
    Xiaoling Fang
    Archives of Gynecology and Obstetrics, 2020, 301 : 707 - 714
  • [10] Silencing TBX1 Exerts Suppressive Effects on Epithelial-Mesenchymal Transition and Inflammation of Chronic Rhinosinusitis Through Inhibition of the TGFβ-Smad2/3 Signaling Pathway in Mice
    Zhong, Yu
    Li, Yunqiu
    Zhang, Hua
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2020, 34 (01) : 16 - 25
12345